Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Joseph D’Orazio Discusses Xylazine with WBUR

View All News

Joseph D’Orazio, MD, Associate Professor of Clinical Emergency Medicine at the Lewis Katz School of Medicine at Temple University, spoke with WBUR about xylazine, an animal tranquilizer that is not approved for humans but has shown up in fentanyl and cocaine. Xylazine is a sedative that slows breathing, blood pressure and heart rate. Dr. D’Orazio discussed the challenges of treating xylazine withdrawal and treating wounds from xylazine use.